Especially, eotaxin, MCP-1, and MIP-1β were markedly decreased in NSCLC patients of the pre-RT group, in comparison with the HC group, but they and BLC were significantly elevated after radiotherapy compared with the pre-RT group (Figures 7(a)–7(d)). The gene discussed is CCL2; the disease is non-small cell lung carcinoma.